Brief: Vivesto Enters Licensing Agreement With Zhejiang Zhida Pharmaceutical
18/03/2025 06:16
March 18 (Reuters) - Vivesto AB VIVE.ST: ENTERED LICENSING AGREEMENT WITH ZHEJIANG ZHIDA PHARMACEUTICAL FOR DEVELOPMENT, PRODUCTION AND COMMERCIALIZATION OF APEALEA Source text: ID:nMFN4ptWBC Further company coverage: VIVE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO